CVS250502P46500
- 0.10
- 0.000.00%
CVS Health Newsroom
Is CVS Health Stock (CVS) a Buy Ahead of Earnings?
Option Care Health Upgraded at UBS on Valuation After Q1 Beat
CVS Q1 Earnings Preview: Street Sees 27% Increase in Profit
CVS Health Corporation (NYSE:CVS) Is a Favorite Amongst Institutional Investors Who Own 83%
Aetna to Change Pre-Authorization Process for Some Cancer Care
CVS Health Q1 Earnings to Benefit From Favorable Medical Loss Ratio, UBS Says
9 Health Care Stocks Whale Activity In Today's Session
Cramer's Warning: Tariff Chaos Could Derail Tech Earnings Frenzy This Week
The Trader: Buy Healthcare Stocks Despite RFK Jr., Tariffs, and UnitedHealth
Earnings Preview: CVS Health to Report Financial Results on May 01
Leerink Partners Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $79
CVS Health Positioned for Growth: Buy Rating Affirmed Amid Earnings Recovery and Strategic Improvements
CVS Health Corp. (CVS) Rebounded in Q1
Express News | CVS Health Corp : Leerink Partners Raises Target Price to $79 From $75
CVS Group's Crematorium Division Sale Is Attractive -- Market Talk
Is CVS Health Corporation (CVS) the Best Stock That Will Always Grow?
CVS Health (CVS) Ascends But Remains Behind Market: Some Facts to Note
Despite Medicaid Pressure, Elevance Health Delivers Strong Q1 Performance, Reiterates Profit Outlook
CVS Health Corporation (CVS): Among Recent Activist Investor Campaigns
Fund Update: Canoe Financial LP Opened a $94.1M Position in $CVS Stock